Division of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Ann Thorac Surg. 2011 Sep;92(3):998-1005; discussion 1005-6. doi: 10.1016/j.athoracsur.2011.05.018.
More than 11 million Americans live with chronic lung disease; in search for an alternative to donor organs, we attempted to regenerate lungs based on perfusion decellularized lung scaffolds that can be transplanted similar to a donor organ.
Cadaveric rat lungs were decellularized by detergent perfusion. Resulting scaffolds were mounted in bioreactors and seeded with endothelial and fetal lung cells. Biomimetic organ culture was maintained for 7 days. Resulting bioartificial left lungs were transplanted in orthotopic position after left pneumonectomy in rats. Cadaveric left lung transplants and pneumonectomies served as controls. Blood gas analyses, compliance testing, and fluoroscopies were performed on postoperative days 1, 7, and 14. Lungs were removed for final analysis on day 14.
Perfusion decellularization of cadaveric lungs yielded acellular scaffolds with intact architecture and matrix composition. Alveolar volumes, number, and size were comparable in bioartificial and native lungs, as were gas exchange, vital capacity and compliance in vitro. After using improved graft preservation and postoperative weaning protocols, animals could be fully recovered, and bioartificial lung constructs provided oxygenation as long as 7 days at levels comparable to cadaveric lung transplants. Compliance, gas exchange, and radiographic appearance gradually declined over the subsequent 7 days owing to progressive graft consolidation and inflammation.
Perfusion decellularization of cadaveric lungs yields intact scaffolds that can be seeded with cells to generate bioartificial lung grafts. After orthotopic transplantation, grafts are perfused by the recipient's circulation, ventilated through the recipient's airway and provide gas exchange in vivo for 7 days.
超过 1100 万美国人患有慢性肺部疾病;为了寻找替代供体器官的方法,我们尝试基于可移植的灌注去细胞化肺支架来再生肺,其方式类似于供体器官。
通过去污剂灌注对尸体大鼠肺进行去细胞化。所得支架被安装在生物反应器中,并接种内皮细胞和胎肺细胞。进行仿生器官培养 7 天。在大鼠左肺切除术后,将左肺生物人工左肺原位移植。尸体左肺移植和左肺切除术作为对照。术后第 1、7 和 14 天进行血气分析、顺应性测试和荧光透视检查。第 14 天取出肺进行最终分析。
尸体肺的灌注去细胞化产生了具有完整结构和基质组成的无细胞支架。生物人工肺和天然肺的肺泡体积、数量和大小相当,体外气体交换、肺活量和顺应性也相当。使用改进的移植物保存和术后断奶方案后,动物可以完全恢复,生物人工肺结构可以提供长达 7 天的氧合,其水平与尸体肺移植相当。在随后的 7 天中,由于移植物逐渐融合和炎症,顺应性、气体交换和影像学表现逐渐下降。
尸体肺的灌注去细胞化产生完整的支架,可接种细胞生成生物人工肺移植物。原位移植后,移植物通过受者的循环灌注,通过受者的气道通气,并在体内提供 7 天的气体交换。